VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
MEDPMedpace Holdings, Inc.
$455.66$13.0B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksMEDPEarnings History

MEDP logoMedpace Holdings, Inc. (MEDP) Earnings History

Elite Compounder

12 years of earnings data (2014–2025) · 5-year EPS CAGR exceeds 18% — top-tier earnings quality

TTM Net Income
$460M
● Profitable
TTM EPS (Diluted)
$15.90
Per share, diluted
YoY EPS Growth
+21.0%
Excellent
Net Margin
17.8%
After-tax profitability
EPS Growth Rate (CAGR)
1Y+21.0%
3Y+28.0%
5Y+31.8%
10YN/A
Operating Margin21.1%
Gross Margin30.1%
Return on Equity70.2%
Return on Assets22.1%
Record Annual Net Income$451MFY2025
Record Quarterly EPS$4.67Q4 2025
Consecutive Profitable Years10years
Q1 2026
Net Income$124M
EPS (Diluted)$4.28
YoY Growth+21.0%Excellent
QoQ Growth-8.3%Slow

Loading earnings history...

Medpace Holdings, Inc. (MEDP) Earnings Overview

As of June 23, 2026, Medpace Holdings, Inc. (MEDP) reported trailing twelve-month net income of $460M, reflecting +21.0% year-over-year growth. The company earned $15.90 per diluted share over the past four quarters, with a net profit margin of 17.8%.

Looking at the long-term picture, MEDP's 5-year EPS compound annual growth rate (CAGR) stands at +31.8%, indicating exceptional earnings growth. The company achieved its highest annual net income of $451M in fiscal 2025, representing a new all-time high.

Medpace Holdings, Inc. maintains industry-leading profitability with a gross margin of 30.1%, operating margin of 21.1%, and net margin of 17.8%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →

Compared to peers including ICLR ($489M net income, 2.8% margin), CRL (-$185M net income, -3.6% margin), PRA ($65M net income, 4.6% margin), MEDP has outperformed on profitability metrics. Compare MEDP vs ICLR →

MEDP Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
MEDP logoMEDPCurrent
$460M$15.9017.8%70.2%+21.0%—
ICLR logoICLR
$489M$6.192.8%2.5%-69.6%
CRL logoCRL
-$185M$-3.77-3.6%-4.3%-1555.0%
PRA logoPRA
$65M$1.264.6%4.0%-3.9%
HIMS logoHIMS
-$13M$-0.065.5%25.2%-3.8%
IQV logoIQV
$1.4B$8.168.3%21.4%+4.7%
Best in group
Lowest in group

MEDP Historical Earnings Data (2014–2025)

12 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025$451M+11.6%$535M$15.2817.8%21.1%
2024$404M+43.0%$447M$12.6319.2%21.2%
2023$283M+15.3%$337M$8.8815.0%17.9%
2022$245M+34.9%$279M$7.2816.8%19.1%
2021$182M+25.1%$199M$4.8115.9%17.4%
2020$145M+44.7%$167M$3.8415.7%18.0%
2019$100M+37.2%$127M$2.6711.7%14.8%
2018$73M+87.1%$101M$1.9710.4%14.3%
2017$39M+191.4%$65M$0.989.0%14.9%
2016$13M+254.8%$52M$0.373.2%12.5%
2015-$9M+44.3%$21M$-0.28-2.4%5.7%
2014-$16M-$26M$-0.53-5.4%9.0%

Download Data

Export MEDP earnings history in CSV or JSON format

Free sign-in required to download data

Consensus-Based Analysis Tools

Full Stock Analysis

Deep dive into MEDP consensus models and risk factors.

View Analysis

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

12+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

MEDP — Frequently Asked Questions

Quick answers to the most common questions about buying MEDP stock.

What is MEDP earnings per share (EPS)?

MEDP trailing twelve-month (TTM) diluted EPS is $15.90, reflecting +21.0% year-over-year growth. The 5-year EPS CAGR is +31.8%. Complete EPS history from 2014 to 2025 is available in the table on this page.

What is Medpace Holdings, Inc.'s net income?

Medpace Holdings, Inc. (MEDP) trailing twelve-month net income is $460M as of 2025. Earnings grew +21.0% year-over-year. Medpace Holdings, Inc. has been profitable for 10 consecutive years.

Is MEDP profitable?

Yes, MEDP is profitable with a TTM net income of $460M and a net profit margin of +17.8%. Medpace Holdings, Inc. has generated profits for 10 consecutive years.

What is MEDP's earnings growth rate?

MEDP compound annual EPS growth rates (CAGR): 1-Year: +21.0%, 3-Year: +28.0%, 5-Year: +31.8%, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2014 to 2025.

What are MEDP's profit margins?

Medpace Holdings, Inc. net profit margin is +17.8%, operating margin is +21.1%, and gross margin is +30.1%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +70.2%.

Is MEDP growing earnings?

Yes, MEDP earnings are accelerating — EPS growth of +21.0% exceeds the 5-year CAGR of +31.8%. TTM net income reached $460M. Earnings momentum is strengthening.

What was MEDP's best earnings year?

Medpace Holdings, Inc.'s highest annual net income on record is $451M, achieved in fiscal year 2025. Earnings history on this page spans 2014 to 2025 and includes all annual and quarterly figures.

What were MEDP's earnings last quarter?

MEDP's most recent reported quarter was Q1 2026. Net income was $124M with diluted EPS of $4.28. For a full breakdown of all quarters, see the quarterly earnings table on this page.

MEDP Earnings Over Time (2014–2025)

Net income & EPS — annual and quarterly view